...$39.1 million) from France's OSEO agency. The facility is expected to begin operations in 4Q13. Celogos S.A....
...project is developing the first five products to be manufactured: CEL-02, a cell therapy from Celogos...

...treat stress urinary incontinence using Celogos’ rational cell design (RCD) technology for myoblast cell implantation. Celogos’...
...Tokyo, Japan) and Stem Cell Sciences plc (LSE:STEM, Edinburgh, U.K.). Further details were not disclosed. Celogos S.A....

...a common problem for people who undergo certain types of surgery or go through childbirth. Celogos...
...in the U.S., the EU and Japan. Estimates are less clear for anal incontinence, but Celogos...
...host myofibers and contribute to muscle repair, said André Ulmann, chairman and CEO of Celogos. Celogos...

...Celogos was launched by Biotop, the business incubator of the Pasteur Institute. Celogos will focus on...
...Rational Cell Design, combines bioinformatics with cellular technology in efforts to assess cell culture quality. Celogos...

...Celogos (Paris, France) has been launched by Biotop, the business incubator of the Pasteur Institute. Celogos...